Treatment with type I IFNs (IFN-α/β) or the type II IFN (IFN-γ) prior to Cryptosporidium infection has been shown to enhance resistance to infection (12, 13), while a novel role for type III IFN (IFN-λ) in anti-C. This evidence concerns the gene IFNA1 and infection.